Millie Das
Key Documents
Contact Information
-
Clinical Offices
Stanford Cancer Center 875 Blake Wilbur Dr MC 5821 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 725-9113
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Thoracic Oncology
- Medical Oncology
Professional Education
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2011) |
| Internship: | Stanford University Hospital - Internal Medicine CA (2005) |
| Residency: | Stanford University Hospital - Internal Medicine CA (2007) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2011) |
| Fellowship: | Stanford University School of Medicine CA (2011) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2007) |
Scientific Focus
Publications
- A case series of NSCLC patients with different molecular characteristics and choroidal metastases: improvement in vision with treatment including pemetrexed and bevacizumab. J Thorac Oncol. 2013; (2): e17-8
- Angiogenesis inhibitors. J Thorac Oncol. 2012; (16 Suppl 5): S397-8
- ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy. Lung Cancer. 2012; (2): 421-6
- Angiogenesis inhibitors. J Thorac Oncol. 2011; (11 Suppl 4): S1801-2
- Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011; (5): 280-5
- Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? Curr Treat Options Oncol. 2010; (1-2): 24-35
Help